Saeed Mohammed Abdel Monem, Mohamed Alaa Hussein, Owaynat Ahmed Hassan
Critical Care Medicine Department, Faculty of Medicine Helwan University, Helwan, Egypt.
Clinical Pharmacy Department, Helwan University Hospitals, Helwan, Egypt.
Egypt J Intern Med. 2022;34(1):23. doi: 10.1186/s43162-022-00116-w. Epub 2022 Feb 21.
Cholecalciferol is an important nutrient and essential to build body, maintain strong bones, and improves immunity.The main source for vitamin D is the body's skin which absorbs the sun's ultraviolet rays and convert them into vitamin D; at the same time, deficiency can occur or people may not get enough supplementation; this occurs mainly in old age, not taking healthy food, or have darker skin, and this deficient cases can raise the risk of severe COVID-19 if infected.Vitamin D boosts immunity and decreases inflammation. Poorer outcome of corona virus-disease (COVID-19) has been suggested to be due to vitamin D deficiency.We suggested to find the effect of cholecalciferol levels 25-hydroxy vitamin D (25 OHD) on the severity and mortality in patients suffering from COVID-19.
Our study is a prospective following of 414 patients admitted in Helwan University Hospitals in the period of June 2020 till October 2021 for severely symptomatic. COVID-19 patients with median of age 54.55 ± 14.27, with a definite range of APACHE II score ranging from 15 to 19 where we measured vitamin D level (cholecalciferol level), correlating the assay level to the inflammatory cytokine storm markers on admission, on the fifth day and after 10 days also the level of vitamin D was correlated to the length of stay mechanical ventilation days and mortality.
Lower level of vitamin D on admission was strongly evident in patients with severely symptomatic and in mortality of COVID-19 patients 58.25 ± 24.59 nmol/L when compared with patients who survived 103.97 ± 36.14 nmol/L with value < 0.001.Also, when correlating the initial level of vitamin D on admission with the level of the inflammatory cytokine storm markers on admission, on fifth day from admission and on the tenth day, it shows a strong inverse correlation between vitamin D level on admission and ferritin level on fifth day ρ-0.739 value < 0.001 also on the tenth day ρ-0.885, value < 0.001, in comparing also with D-dimer on fifth day ρ-0.858, value < 0.001 also showing a strong inverse correlation with a highly significant value this also evident on the D-dimer level on the tenth day ρ-0.889 with value < 0.001, CRP at fifth and tenth day ρ-0.868, value < 0.001, ρ-0.891, value < 0.001 respectively also in correlating the LDH level on the fifth and tenth day with the initial level of vitamin D it shows a strong inverse correlation with a highly significant value. ρ-0.887, value < 0.001, ρ-0.878, value < 0.001 respectively, in the fifth and tenth day. Neutrophil to lymphocyte ratio was strongly, inversely correlated to the vitamin D level (cholecalciferol) on admission with ρ-0.753, < 0.001, ρ-0.882, < 0.001 respectively. Also, chest computed tomography in the fifth and tenth day of admission showed a very strong inverse correlation with vitamin D level and a highly significant statistical difference ρ-0.655, value < 0.001 respectively.Length of stay and mechanical ventilation days were also strongly inversely correlated to the cholecalciferol level ρ-0.795, < 0.001, ρ- 0.879, < 0.001 ROC curve of vitamin D to predict mortality (RR 0.865, 95% CI 0.828-0.896, < 0.001, with cut off-value for vit. D < 60 nmol/L, regardless of other factors like age, gender, and presence of other co-morbidities.
Low level of cholecalciferol was strongly inversely correlated with cytokine storm markers and independent predictor of severity and mortality in COVID-19 patients.
胆钙化醇是一种重要营养素,对身体发育、维持骨骼强健及提高免疫力至关重要。维生素D的主要来源是人体皮肤,其吸收太阳紫外线并将其转化为维生素D;同时,可能会出现维生素D缺乏或人们补充不足的情况;这主要发生在老年人、未摄入健康食物或皮肤较黑的人群中,而这种缺乏情况若感染新冠病毒,会增加患重症COVID-19的风险。维生素D可增强免疫力并减轻炎症。有研究表明,冠状病毒病(COVID-19)预后较差可能与维生素D缺乏有关。我们建议研究25-羟基维生素D(25 OHD)水平的胆钙化醇对COVID-19患者病情严重程度和死亡率的影响。
我们的研究是对2020年6月至2021年10月期间在赫尔万大学医院收治的414例有严重症状的患者进行前瞻性随访。这些COVID-19患者的年龄中位数为54.55±14.27岁,急性生理与慢性健康状况评分系统(APACHE II)评分为15至19分,我们测量了维生素D水平(胆钙化醇水平),将检测水平与入院时、第5天和10天后的炎症细胞因子风暴标志物进行关联,同时将维生素D水平与机械通气天数和住院时间以及死亡率进行关联。
与存活患者的103.97±36.14 nmol/L相比,有严重症状的COVID-19患者入院时维生素D水平较低,为58.25±24.59 nmol/L,P值<0.001。此外,将入院时维生素D的初始水平与入院时、入院第5天和第10天的炎症细胞因子风暴标志物水平进行关联时,结果显示入院时维生素D水平与第5天铁蛋白水平呈强烈负相关,ρ=-0.739,P值<0.001,第10天时ρ=-0.885,P值<0.001;与第5天D-二聚体相比,ρ=-0.858,P值<0.001,也显示出强烈负相关且具有高度显著性P值,第10天D-二聚体水平ρ=-0.889,P值<0.001;第5天和第10天的C反应蛋白(CRP)分别为ρ=-0.868,P值<0.001,ρ=-0.891,P值<0.001;将第第5天和第10天的乳酸脱氢酶(LDH)水平与维生素D的初始水平进行关联时,也显示出强烈负相关且具有高度显著性P值,第5天和第10天分别为ρ=-0.887,P值<0.001,ρ=-0.878,P值<0.001。中性粒细胞与淋巴细胞比值与入院时维生素D水平(胆钙化醇)呈强烈负相关,分别为ρ=-0.753,P<0.001,ρ=-0.882,P<0.001。此外,入院第5天和第10天的胸部计算机断层扫描显示与维生素D水平呈非常强烈的负相关且具有高度显著的统计学差异,分别为ρ=-0.655,P值<0.001。住院时间和机械通气天数也与胆钙化醇水平呈强烈负相关,ρ=-0.795,P<0.001,ρ=-0.879,P<0.001。维生素D预测死亡率的ROC曲线(风险比0.865,95%置信区间0.828-0.896,P<0.001),维生素D临界值<60 nmol/L,不受年龄、性别和其他合并症等其他因素影响。
胆钙化醇水平低与细胞因子风暴标志物呈强烈负相关,是COVID-19患者病情严重程度和死亡率的独立预测指标。